Agencies
Services
Drugs and Therapeutics (D & T) Committee Drugs Under Review for: March 14, 2012
| Drug Name | Review Type | Class | Manufacturer |
| Juvisync | New Drug Initial Review | Diabetes/Cholesterol | Merck and Co. Inc |
| Eylea | New Drug Initial Review | VEGF Inhibitor | Regeneron |
| Pedipirox-4 Nail Kit | New Drug Initial Review | Antifungal � Topical | Pedinol |
| Complera | New Drug Appeal | HIV | Gilead |
| Natroba | New Drug Appeal | Pediculicide | ParaPRO, LLC |